CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

1,460

Participants

Timeline

Start Date

September 30, 2004

Conditions
Arterial Occlusive Diseases
Interventions
DRUG

Clopidogrel

Trial Locations (14)

Unknown

Sanofi-Aventis, North Ryde

Sanofi-Aventis, Vienna

Sanofi-Aventis, Brussels

Sanofi-Aventis, Helsinki

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Budapest

Sanofi-Aventis, Milan

Sanofi-Aventis, Gouda

Sanofi-Aventis, Warsaw

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Stockholm

Sanofi-Aventis, Meyrin

Sanofi-Aventis, Guildford

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY